A 3D model of a tumor is shown with red blood vessels and blue and red spots showing the many cells involved in the tumor, against a black background.
Webinars

Exploring new frontiers in pancreatic cancer treatment with spatial biology

Learn how spatial profiling and patient-derived models uncover what drives therapy resistance in pancreatic cancer.

This webinar is now available on-demand.

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, with limited treatment options and a high recurrence rate. Emerging research suggests that the tumor microenvironment (TME) and metastatic site play a critical role in therapy response. In this webinar, Yana Zavros will discuss how she combined spatial biology and patient-derived organoids (PDOs) to uncover a distinct cell population driving therapy resistance and disease recurrence in PDAC.

Topics to be covered:

  • Mapping the TME across metastatic sites to guide treatment strategies
  • Using spatial biology and PDOs to identify therapy-resistant cell populations in PDAC 
  • An introduction to high throughput multiplex immunofluorescence for TME characterization


Tuesday, May 6th, 2025 | 11:00 AM - 12:30 PM Eastern Time

Speakers

Yana Zavros, PhD

Yana Zavros, PhD
Research Center Director and GRA Eminent Scholar in Molecular Medicine
University of Georgia School of Medicine

Tad George, PhD

Tad George, PhD
Senior Vice President, Biology R&D
RareCyte Inc.

Sponsored by

  • RareCyte

Top Image Credit:

Credit: iStock.com/Marcin Klapczynski